These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 26407269)

  • 1. Piperacillin-Tazobactam Usage at a Tertiary Pediatric Hospital: An Antimicrobial Stewardship Review.
    Janowski AB; Michaels MG; Martin JM; Green MD
    J Pediatric Infect Dis Soc; 2016 Sep; 5(3):342-5. PubMed ID: 26407269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program.
    Liu P; Ohl C; Johnson J; Williamson J; Beardsley J; Luther V
    BMC Infect Dis; 2016 Dec; 16(1):751. PubMed ID: 27955625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective evaluation of piperacillin-tazobactam, imipenem-cilastatin and meropenem used on surgical floors at a tertiary care hospital in Saudi Arabia.
    Youssif E; Aseeri M; Khoshhal S
    J Infect Public Health; 2018; 11(4):486-490. PubMed ID: 29153444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Piperacillin/Tazobactam Shortage: Central Restriction and Alternative Recommendations as Effective Antibiotic-Stewardship Intervention at a Maximal Care Hospital].
    Kessel J; Dolff B; Wichelhaus T; Keiner N; Hogardt M; Reinheimer C; Wieters I; Harder S; Kempf VAJ; Stephan C;
    Dtsch Med Wochenschr; 2018 Apr; 143(8):e59-e67. PubMed ID: 29237206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective cohort study of inappropriate piperacillin-tazobactam use for lower respiratory tract and skin and soft tissue infections: Opportunities for antimicrobial stewardship.
    Havey TC; Hull MW; Romney MG; Leung V
    Am J Infect Control; 2015 Sep; 43(9):946-50. PubMed ID: 26159502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK.
    Prabhu V; Foo J; Ahir H; Sarpong E; Merchant S
    J Med Econ; 2017 Aug; 20(8):840-849. PubMed ID: 28532194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of non-antibiotic recommendations by a multi-disciplinary antimicrobial stewardship team.
    Ng TM; Phang VY; Young B; Tan SH; Tay HL; Tan MW; Ling LM; Ang BS; Teng CB; Lye DC
    Int J Antimicrob Agents; 2017 Aug; 50(2):166-170. PubMed ID: 28625717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Economic Impact of Empirical Extended-Infusion Piperacillin-Tazobactam in a Community Medical Center.
    Brunetti L; Poustchi S; Cunningham D; Toscani M; Nguyen J; Lim J; Ding Y; Nahass RG
    Ann Pharmacother; 2015 Jul; 49(7):754-60. PubMed ID: 25855703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin vs. Vancomycin/Piperacillin-Tazobactam-Associated Acute Kidney Injury in Noncritically Ill Patients at a Tertiary Care Military Treatment Facility.
    Anderson CW; Cazares KS; Lustik MB; Patel SM; Denunzio TM
    Mil Med; 2017 Sep; 182(9):e1773-e1778. PubMed ID: 28885936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Perioperative antibiotic prophylaxis in radical retropubic prostatectomy: a randomised pilot study of perioperative and postoperative administration].
    Schenck M; Luetzke A; Ruebben H; Schneider T
    Aktuelle Urol; 2011 Jan; 42(1):38-45. PubMed ID: 21267804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of computerized pre-authorization of broad spectrum antibiotics in Pseudomonas aeruginosa at a children's hospital in Japan.
    Horikoshi Y; Higuchi H; Suwa J; Isogai M; Shoji T; Ito K
    J Infect Chemother; 2016 Aug; 22(8):532-5. PubMed ID: 27263807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness evaluation of ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections accounting for antibiotic resistance.
    Jansen JP; Kumar R; Carmeli Y
    Value Health; 2009; 12(2):234-44. PubMed ID: 20667059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
    LeCleir LK; Pettit RS
    Pediatr Pulmonol; 2017 Aug; 52(8):1000-1005. PubMed ID: 28440913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of generic formulation of piperacillin/tazobactam (Astaz-P) for treatment of infected patients at Siriraj Hospital.
    Charoenpong L; Tongsai S; Thamlikitkul V
    J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S104-10. PubMed ID: 23590029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperacillin-Tazobactam-induced Adverse Drug Events in Pediatric Patients on Outpatient Parenteral Antimicrobial Therapy.
    Yusef D; Gonzalez BE; Foster CB; Goldfarb J; Saracusa C; Worley S; Sabella C
    Pediatr Infect Dis J; 2017 Jan; 36(1):50-52. PubMed ID: 27749652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.
    Yost RJ; Cappelletty DM;
    Pharmacotherapy; 2011 Aug; 31(8):767-75. PubMed ID: 21923603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to European Association of Urology Guidelines on Prophylactic Antibiotics: An Important Step in Antimicrobial Stewardship.
    Cai T; Verze P; Brugnolli A; Tiscione D; Luciani LG; Eccher C; Lanzafame P; Malossini G; Wagenlehner FM; Mirone V; Bjerklund Johansen TE; Pickard R; Bartoletti R
    Eur Urol; 2016 Feb; 69(2):276-83. PubMed ID: 26001610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of extended-infusion piperacillin-tazobactam: a retrospective analysis of critically ill patients.
    Lee GC; Liou H; Yee R; Quan CF; Neldner K
    Clin Ther; 2012 Dec; 34(12):2297-300. PubMed ID: 23195962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empirical antibiotic treatment with piperacillin-tazobactam in patients with microbiologically-documented biliary tract infections.
    Bassotti G; Chistolini F; Sietchiping-Nzepa F; De-Roberto G; Morelli A
    World J Gastroenterol; 2004 Aug; 10(15):2281-3. PubMed ID: 15259083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of a Piperacillin/Tazobactam Shortage on Antimicrobial Prescribing and Clostridium difficile Risk in 88 US Medical Centers.
    Gross AE; Johannes RS; Gupta V; Tabak YP; Srinivasan A; Bleasdale SC
    Clin Infect Dis; 2017 Aug; 65(4):613-618. PubMed ID: 28444166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.